SU2C Dream TeamTargeting the PI3K Pathway In Women's Cancers
Enroll in Clinical Trials Essential Information Headlines Meet the Dream Team

Thousands of patients diagnosed with cancer volunteer to participate in clinical trials every day. Their willingness to participate in these studies enables clinical research to meet the challenge to find new treatments and potential cures.

The availability of well-designed clinical trials in breast, endometrial and ovarian cancers offer patients a true opportunity to engage actively in their own healthcare, to benefit from receiving state-of-the-art treatment, and to contribute authentically toward improved outcomes for all patients with these cancers.

The goal of our SU2C Dream Team is to discover approaches that will predict the patients who will respond to PI3K pathway inhibitors; thereby, accelerating drug approvals and ultimately providing targeted therapy techniques for personalized tailored cancer treatments that can be incorporated into standard practice to improve patient outcomes.

For more information, visit

design by Digizyme ©2010 SU2C Dream Team
Targeting the PI3K Pathway in Women's Cancers
Stand Up To Cancer American Association for Cancer Research